We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+13.7%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$58.6B
AUM Growth
+$6.88B
Cap. Flow
+$673M
Cap. Flow %
1.15%
Top 10 Hldgs %
15.13%
Holding
2,345
New
99
Increased
633
Reduced
672
Closed
693

Top Sells

Rank Stock Value
1
ICE icon
Intercontinental Exchange
ICE
+$140M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$134M
3
FDX icon
FedEx
FDX
+$111M
4
KMI icon
Kinder Morgan
KMI
+$88.7M
5
ENB icon
Enbridge
ENB
+$61.3M

Sector Composition

Rank Sector Weight
1 Healthcare 17.63%
2 Financials 15.15%
3 Technology 13.23%
4 Industrials 8.77%
5 Energy 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
USFD icon
726
US Foods
USFD
$21.4B
$5.98M 0.01%
171,250
+200
+0.1% +$6.86K
EFV icon
727
iShares MSCI EAFE Value ETF
EFV
$27.6B
$5.96M 0.01%
+122,000
New +$5.87M
DRI icon
728
Darden Restaurants
DRI
$22.5B
$5.96M 0.01%
49,049
-12,531
-20% -$1.37M
PE
729
DELISTED
PARSLEY ENERGY INC
PE
$5.96M 0.01%
308,681
+16,292
+6% +$299K
TSCO icon
730
Tractor Supply
TSCO
$16.3B
$5.95M 0.01%
304,420
-113,395
-27% -$2.06M
CTSH icon
731
Cognizant
CTSH
$21.5B
$5.93M 0.01%
81,811
-14,188
-15% -$993K
WST icon
732
West Pharmaceutical
WST
$23.1B
$5.91M 0.01%
53,612
-56,678
-51% -$5.9M
CHRS icon
733
Coherus Oncology
CHRS
$217M
$5.87M 0.01%
430,000
-300
-0.1% -$4K
HRC
734
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$5.83M 0.01%
55,108
+1,454
+3% +$146K
WOLF icon
735
Wolfspeed
WOLF
$1.2B
$5.8M 0.01%
101,445
TJX icon
736
TJX Companies
TJX
$170B
$5.74M 0.01%
107,966
+13,326
+14% +$664K
MIDD icon
737
Middleby
MIDD
$6.05B
$5.72M 0.01%
44,020
+20,110
+84% +$2.41M
SIVB
738
DELISTED
SVB Financial Group
SIVB
$5.72M 0.01%
25,733
-4
-0% -$931
TCF
739
DELISTED
TCF Financial Corporation Common Stock
TCF
$5.71M 0.01%
138,727
+23,435
+20% +$1.01M
MAA icon
740
Mid-America Apartment Communities
MAA
$15.6B
$5.71M 0.01%
52,168
+773
+2% +$79.5K
BMO icon
741
Bank of Montreal
BMO
$125B
$5.68M 0.01%
75,951
RVTY icon
742
Revvity
RVTY
$12.3B
$5.67M 0.01%
58,822
+4,197
+8% +$378K
CLH icon
743
Clean Harbors
CLH
$16.1B
$5.65M 0.01%
78,963
+78,363
+13,061% +$4.84M
MPT
744
Medical Properties Trust
MPT
$2.89B
$5.6M 0.01%
302,700
+3,900
+1% +$69.5K
GLPI icon
745
Gaming and Leisure Properties
GLPI
$12.8B
$5.59M 0.01%
144,981
+29,981
+26% +$1.09M
NKTR icon
746
Nektar Therapeutics
NKTR
$2.39B
$5.58M 0.01%
11,073
NLY icon
747
Annaly Capital Management
NLY
$16.9B
$5.58M 0.01%
139,522
+70,087
+101% +$2.86M
DVAX
748
DELISTED
Dynavax Technologies
DVAX
$5.56M 0.01%
760,000
+260,000
+52% +$2.54M
CBPO
749
DELISTED
China Biologic Products Holdings, Inc.
CBPO
$5.54M 0.01%
60,756
-50,400
-45% -$4.12M
QIWI
750
DELISTED
QIWI PLC
QIWI
$5.54M 0.01%
385,284

Similar funds

Macquarie Group's Q1 2019 Portfolio in Review

As of Q1 2019, Macquarie Group held 2,345 positions worth $58.6B, up 13% from $51.8B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Macquarie Group's Q1 2019 filing shows 99 new, 633 increased, 672 reduced and 693 closed positions. Its largest new stake was Takeda Pharmaceutical: 4,781,268 shares worth $97.4M. The largest sale was Intercontinental Exchange, an estimated $140M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 19% a quarter earlier, followed by Financials and Technology.

  • Macquarie Group's largest Q1 2019 buy was Takeda Pharmaceutical: 4,781,268 shares worth $97.4M.
  • Macquarie Group added most to Broadcom in Q1 2019, an estimated $700M increase.
  • Macquarie Group's biggest Q1 2019 reduction was Intercontinental Exchange, cutting an estimated $140M.
  • Macquarie Group fully exited FCB Financial Holdings, Inc. in Q1 2019, selling an estimated $30.2M.
  • Macquarie Group's ten largest holdings make up 15% of its $58.6B portfolio in Q1 2019.
  • Macquarie Group opened 99 new positions and closed 693 in Q1 2019.
  • Macquarie Group's portfolio value rose 13% quarter-over-quarter to $58.6B.

Based on Macquarie Group's 13F filing for Q1 2019, filed 15 May 2019.